←
IMO1,909 posts
IMO avatar

IMO

@mathonco

The Integrated Mathematical Oncology department uses the integration of theory & experiments to better understand cancer initiation, progression & treatment.

◷ Joined October 2014▧ 27 Photos and videos
IMO avatar
IMO@mathonco·Oct 16

And you can do a PhD in #MathOnco with some of the leaders in the field. Fully paid program and stipend included!

Advance your career with Moffitt’s Cancer PhD Program! Gain hands-on research experience, learn from leading scientists and explore specialized majors focused on advancing cancer research. Application deadline: Dec. 1, 2026. Learn more and apply today: bit.ly/3YH7yfH

Post attachment
Moffitt Cancer Center avatar
⟳ IMO retweeted
Moffitt Cancer Center@MoffittNews·Oct 15

Advance your career with Moffitt’s Cancer PhD Program! Gain hands-on research experience, learn from leading scientists and explore specialized majors focused on advancing cancer research. Application deadline: Dec. 1, 2026. Learn more and apply today: bit.ly/3YH7yfH

Post attachment
Kimberly Luddy avatar
⟳ IMO retweeted
Kimberly Luddy@luddyka·Jul 29

Full circle moment. I've been a researcher @MoffittNews for over 20 years and this Friday, my son Nathan will present his own research through Moffitt's High school math-oncology internship. "Optimizing Ovarian Cancer Treatment Times Based on MGMT Circadian Rhythm." So Proud!

Post attachmentPost attachment
Moffitt Cancer Center avatar
⟳ IMO retweeted
Moffitt Cancer Center@MoffittNews·Jul 12

Don’t miss Renee Brady, PhD, tomorrow at SMB #ECMTB2026, where she will share research using mechanistic models of PSA dynamics to characterize patient-specific prostate cancer treatment response and disease progression, with the goal of informing more personalized treatment strategies. #MoffittECMTB2026 Learn more: bit.ly/4ycWre1

Post attachment
Moffitt Cancer Center avatar
⟳ IMO retweeted
Moffitt Cancer Center@MoffittNews·Jul 12

Tomorrow at SMB #ECMTB2026 Diya Upadhyaya presents research combining mathematical modeling and patient-reported outcomes to forecast treatment response and disease progression in patients with non-small cell lung cancer, to support more personalized clinical decision-making. #MoffittECMTB2026 Learn more: bit.ly/4ydVdPK

Post attachment